Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia

Epidemiology and Infection

Volumn 138, Issue 4, 2010, Pages 457-468

  Gao, Z ^a   Gidding, H F ^b   Wood, J G ^a   Macintyre, C R ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Modelling; Vaccination (immunization); Varicella zoster

Indexed keywords

VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CHILD; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; HERPES ZOSTER; HUMAN; IMMUNITY; INFANT; LONG TERM CARE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MORBIDITY; NONHUMAN; PREVENTIVE HEALTH SERVICE; SENSITIVITY ANALYSIS; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION; CHICKENPOX; COMPUTER SIMULATION; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; THEORETICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, THEORETICAL; VACCINATION; YOUNG ADULT;

EID: 77949381136     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990860     Document Type: Article

References (30)

1. Seward JF, et al. Contagiousness of varicella in vaccinated cases - a household contact study. Journal of the American Medical Association 2004; 292: 704-708.
2. Brotherton J, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence 2007; 31 (Suppl.) : S82-S101.
3. Australian Government. The Australian Immunisation Handbook, 9th edn. Australian Government, 2008, pp. 309-321.
4. Brisson M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiology and Infection 2001; 127: 305-314
5. Macartney KK, et al. Varicella vaccination in Australia. Journal of Paediatrics and Child Health 2005; 41: 544-552.
6. Vazquez M, et al. The effectiveness of the varicella vaccine in clinical practice. New England Journal of Medicine 2001; 344: 955-956.
7. Tugwell BD, et al. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004; 113: 455-459.
8. Chaves SS, et al. Loss of vaccine-induced immunity to varicella over time. New England Journal of Medicine 2007; 356: 1121-1129.
9. Marin M, et al. Prevention of varicella : recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2007; 56(RR-4): 1-40.
10. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States : a review of successes and challenges. Pediatrics 2008; 122: e744-e751.
11. Gidding HF, Brisson M, MacIntyre CR. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australian and New Zealand Journal of Public Health 2005; 29: 544-551.
12. Brisson M, et al. Modelling the impact of immunisation on the epidemiology of varicella zoster virus. Epidemiology and Infection 2000; 125: 651-669.
13. Brisson M., Edmunds WJ. The cost-effectiveness of varicella vaccination in Canada. Vaccine 2002; 20: 1113-1125.
14. Schuette MC. A qualitative analysis of a model for the transmission of varicella-zoster virus. Mathematical Biosciences 2003; 182: 113-126.
15. Gidding HF, et al. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiology and Infection 2003; 131: 1085-1089.
16. Farrington CP. Modelling forces of infection for measles, mumps and rubella. Statistics in Medicine 1990; 9: 953-967.
17. Brisson M, et al. Analysis of varicella vaccine breakthrough rates : implications for the effectiveness of immunisation programmes. Vaccine 2000; 18: 2775-2778.
18. Kuter B, et al. Ten year follow-up of health children who received one or two injections of varicella vaccine. Pediatric Infectious Disease Journal 2004; 23: 132-137.
19. Michalik DE, et al. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. Journal of Infectious Diseases 2008; 197: 944-949.
20. Anderson RM, May RM. Infectious diseases of humans. Oxford, UK: Oxford University Press, 1991.
21. Brisson M, et al. Exposure to varicella boosts immunity to herpes-zoster : implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500-2507.
22. Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: Impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 2003: 70: S31-S37.
23. Becker NG, Britton T. Estimating vaccine efficacy from small outbreaks. Biometrika 2004; 91: 363-382.
24. Halloran ME, et al. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American Journal of Epidemiology 1997; 10: 789-803.
25. Vessey SJ, et al. Childhood vaccination against varicella : persistence of antibody, duration of protection, and vaccine efficacy. Journal of Pediatrics 2001; 139: 297-304.
26. Arvin A, Gershon A. Control of varicella : why is a twodose schedule necessary? Opinion and analysis. Pediatric Infectious Disease Journal 2006; 25: 475-476.
27. Shinefield H, et al. Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatric Infectious Disease Journal 2005; 24: 670-675.
28. Shinefield H, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatric Infectious Disease Journal 2005; 24: 665-669.
29. Vazquez M, et al. Effectiveness over time of varicella vaccine. Journal of the American Medical Association 2004; 291: 851-855.
30. Oxman MN, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older Adults. New England Journal of Medicine 2005; 352: 2271-2284.